Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Medical Oncology
Published in: Medical Oncology 2/2005

01-06-2005 | Case Report

Acute tumor lysis syndrome triggered by zoledronic acid in a patient with metastatic lung adenocarcinoma

Authors: Mevlut Kurt, Ibrahim K. Onal, Tamer Elkiran, Bulent Altun, Kadri Altundag, MD, Ibrahim Gullu

Published in: Medical Oncology | Issue 2/2005

Login to get access
Metadata
Title
Acute tumor lysis syndrome triggered by zoledronic acid in a patient with metastatic lung adenocarcinoma
Authors
Mevlut Kurt
Ibrahim K. Onal
Tamer Elkiran
Bulent Altun
Kadri Altundag, MD
Ibrahim Gullu
Publication date
01-06-2005
Publisher
Humana Press
Published in
Medical Oncology / Issue 2/2005
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1385/MO:22:2:203

Other articles of this Issue 2/2005

Medical Oncology 2/2005 Go to the issue

Original Article

Treatment of a patient with a nodal peripheral T-cell lymphoma (Angioimmunoblastic T-cell lymphoma) with a human monoclonal antibody against the CD4 antigen (HuMax-CD4)

Original Article

Randomized, open label, prospective study on the effect of zoledronic acid on the prevention of bone metastases in patients with recurrent solid tumors that did not present with bone metastases at baseline

Original Article

The value of serum Bcl-2 levels in advanced lung cancer patients

Original Article

Irinotecan plus cisplatin combination against metastatic gastric cancer

Review

Involvement of the epstein-barr virus in the nasopharyngeal carcinoma pathogenesis

Original Article

Bcl-xl expression in multiple myeloma
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits